NEW YORK (GenomeWeb News) — Pronota has won a €1.9 million ($2.7 million) grant from the Flanders government to further develop its diagnostic and pharmacodiagnostic protein biomarker-discovery and -validation platform, the Belgian company said today.
 
Pronota said the grant, which is being awarded through IWT-Flanders, will be used to expand the development of Pronota's first-generation biomarker-discovery platform by building on its capability to identify low-abundant serum protein biomarkers.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.